Chemotherapy breakthrough? study cut short for esophageal cancer patients
NCT ID NCT03301454
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to find out if patients with metastatic esophageal cancer who were not getting worse after 6 weeks of chemotherapy should continue treatment or stop. It included 15 adults whose cancer had spread and was no longer responding to initial chemo. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER, SQUAMOUS CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre François Baclesse
Caen, 14076, France
-
Centre Hospitalier de Boulogne sur mer
Boulogne-sur-Mer, 62200, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre René Gauducheau
Nantes, 44805, France
-
Hôpital Privé Arras Les Bonnettes
Arras, 62000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.